Should all adult cystic fibrosis patients with repeated nontuberculous mycobacteria cultures receive specific treatment? A 10-year case–control study

Albrecht Christiane, Ringshausen Felix, Ott Sebastian, Wagner Dirk, Rademacher Jessica, Schneider Michael, Welte Tobias, Pletz Mathias W.

Source: Eur Respir J 2016; 47:1575-1577
Journal Issue: May
Disease area: Respiratory infections

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Albrecht Christiane, Ringshausen Felix, Ott Sebastian, Wagner Dirk, Rademacher Jessica, Schneider Michael, Welte Tobias, Pletz Mathias W.. Should all adult cystic fibrosis patients with repeated nontuberculous mycobacteria cultures receive specific treatment? A 10-year case–control study. Eur Respir J 2016; 47:1575-1577

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Long-term follow-up study of patients with pneumoconiosis complicated by nontuberculous mycobacterial lung disease: report of four cases
Source: Eur Respir J 2001; 18: Suppl. 33, 443s
Year: 2001

Clinical outcome of multiple nontuberculous mycobacteria infection among people with bronchiectasis in Taiwan: a cohort study
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020


Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment
Source: Eur Respir J 2003; 21: 478-482
Year: 2003



A randomized study of bronchoscopic blockade of the affected part of a lung as a part the complex treatment of patients with drug-resistant pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012

Non-tuberculous mycobacterium infection in adult patients: a 10-year single-centre experience
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019

Outcomes of patients undergoing treatment for non-tuberculous mycobacteria lung disease
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019

A study of patients with pulmonary tuberculosis and confirmed coexistence of nontuberculous mycobacteria during treatment: Does the use of the additional acid-fast bacilli sputum test lead to shorter hospitalization?
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014


Isophonum usage in treatment of patients with pulmonary tuberculosis and accompanying pathology and elderly patients
Source: Eur Respir J 2002; 20: Suppl. 38, 547s
Year: 2002

Frequency of mycobacteriosis among the patients with positive cultures of nontuberculous mycobacteria (NTM) – 5 year study
Source: Eur Respir J 2004; 24: Suppl. 48, 190s
Year: 2004

A randomized study of the bronchoscopic valve blockade of the affected part of the lung in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis with treatment failure
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013

Incidence and prevalence of non tuberculous mycobacteria [NTM] in adult CF population: A large adult CF centre experience
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


Pulmonary infection with nontuberculous mycobacteria: management and follow up of 5 infected patients
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009


Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020


Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients
Source: Eur Respir J 2001; 18: 306-315
Year: 2001



Prospective study of nontuberculous mycobacteria (NTM) isolates in children with cystic fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 209s
Year: 2002

Presence of concurrent sarcoid-like granulomas indicates better survival in cancer patients: a retrospective cohort study
Source: ERJ Open Res, 6 (4) 00061-2020; 10.1183/23120541.00061-2020
Year: 2020



Routine liver function test monitoring of patients treated for active M.TB infection does not influence management: A real-world retrospective study
Source: International Congress 2018 – Challenges in tuberculosis care
Year: 2018

Mortality outcomes in patients with idiopathic pulmonary fibrosis treated with antifibrotics: a real world study
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021


Comparison of two different cohorts of patients for multidrug-resistant tuberculosis treatment evaluation
Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB)
Year: 2006


The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses
Source: Eur Respir J 2001; 18: Suppl. 33, 473s
Year: 2001